ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1874

Genome-Wide Profiling Identifies Significant Differences Between The T-Lymphocyte and B-Lymphocyte Methylomes In Healthy Individuals

John Glossop1,2, Nicola Nixon2, Richard Emes3, Kim Haworth1, Jonathon Packham2, Peter Dawes2, Anthony Fryer1, Derek Mattey1,2 and William Farrell1, 1Institute for Science and Technology in Medicine, Keele University, Stoke-on-Trent, United Kingdom, 2Rheumatology, Haywood Rheumatology Centre, Stoke-on-Trent, United Kingdom, 3School of Veterinary Medicine and Science, University of Nottingham, Sutton Bonnington, United Kingdom

Meeting: 2013 ACR/ARHP Annual Meeting

Keywords: B cells, DNA Methylation, T cells and epigenetics

  • Tweet
  • Email
  • Print
Session Information

Title: Genetics and Genomics of Rheumatic Disease II

Session Type: Abstract Submissions (ACR)

Background/Purpose: Multiple reports now describe changes to the DNA methylome in a variety of autoimmune disorders, such as rheumatoid arthritis. In many cases, these studies have analysed methylation in mixed cell populations from whole blood. However, the cellular heterogeneity inherent in these approaches may preclude the identification of cell type-specific methylation differences, which may in turn bias identification of disease-specific changes in methylation. To address this possibility, we used genome-wide DNA methylation profiling to identify differences within matched pairs of T-lymphocytes and B-lymphocytes isolated from the blood of healthy individuals.

Methods: Peripheral blood samples were collected from 10 healthy female donors (all Caucasian non-smokers). T- and B-lymphocyte populations were isolated from each individual using magnetic beads and genomic DNA was extracted. Sodium bisulphite converted DNA was hybridised to HumanMethylation450 BeadChips to establish quantitative genome-wide DNA methylation at more than 450,000 CpG sites. Methylation status at individual CpGs was reported as a β-value on a continuous scale ranging from 0 (unmethylated) to 1 (completely methylated). Array processing and identification of differential methylation was performed using NIMBL software. Pyrosequencing was used to validate array data.

Results: Genome-wide methylation was initially determined by analysis of LINE-1 sequences and was significantly higher in B-lymphocytes than matched T-lymphocytes (69.8 vs. 65.2%, p ≤ 0.01). Pairwise analysis identified 679 CpGs, representing 250 genes, which were differentially methylated between T-lymphocytes and B-lymphocytes. Approximately half of the sites (326; 48%) displayed β-value differences of at least 0.5, and a similar number were associated with a CpG island. The majority of the sites (76.6%) were hypermethylated in B-lymphocytes compared with T-lymphocytes. Pyrosequencing analysis of selected candidate CpGs/genes confirmed the array data in all cases. Hierarchical clustering revealed perfect segregation of the samples into two distinct clusters based on cell type. Differentially methylated genes showed enrichment for biological functions/pathways associated with leukocytes and T-lymphocytes.

Conclusion: Matched pairs of T- and B-lymphocytes from healthy individuals possess intrinsic differences in DNA methylation within a restricted set of functionally-related genes. These data provide a foundation for investigating DNA methylation in diseases in which these cell types play important and distinct roles.


Disclosure:

J. Glossop,
None;

N. Nixon,
None;

R. Emes,
None;

K. Haworth,
None;

J. Packham,
None;

P. Dawes,
None;

A. Fryer,
None;

D. Mattey,
None;

W. Farrell,
None.

  • Tweet
  • Email
  • Print

« Back to 2013 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/genome-wide-profiling-identifies-significant-differences-between-the-t-lymphocyte-and-b-lymphocyte-methylomes-in-healthy-individuals/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology